Status:

COMPLETED

Early Goal-Directed Therapy Utilizing Transpulmonary Thermodilution and Severe Burn Injury

Lead Sponsor:

Chang Gung Memorial Hospital

Conditions:

Burns

Eligibility:

All Genders

18-100 years

Brief Summary

This study aimed to optimize fluid resuscitation with transpulmonary thermodilution (TPTD)-guided protocol and to lower the mortality rate of the severely burned.

Eligibility Criteria

Inclusion

  • Adult patients (age \> 18 years).
  • Major burn (as total burned surface area (TBSA) \> 20% with at least second degree burn depth).
  • Admitted to the intensive care unit (ICU) of the Burn Center.

Exclusion

  • Patients younger than 18 years old.
  • Patients with severe cardiopulmonary diseases, or associated with other major trauma.
  • Patient with incomplete data.

Key Trial Info

Start Date :

August 7 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 20 2022

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT05420610

Start Date

August 7 2021

End Date

January 20 2022

Last Update

June 15 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan, 83301